Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2006-05-16
2006-05-16
Gambel, Phillip (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S139100, C424S141100, C424S143100, C424S144100, C424S173100, C435S252300, C435S252330, C435S320100, C530S387100, C530S387900, C530S388100, C530S388200, C530S388220, C530S388700, C530S388730, C530S389100, C530S389600, C536S023100, C536S023500
Reexamination Certificate
active
07045128
ABSTRACT:
Ligands for flt3 receptors capable of transducing self-renewal signals to regulate the growth, proliferation or differentiation of progenitor cells and stem cells are disclosed. The invention is directed to anti-flt3-L antibodies and enzyme-linked immunosorbent assays comprising such antibodies.
REFERENCES:
patent: 5185438 (1993-02-01), Lemischka
patent: 6630143 (2003-10-01), Lyman et al.
patent: WO 94 26891 (1994-11-01), None
Lyman et al,Cell, 75:1157-1167 (1993).
Rosnet et al,Oncogene, 6:1641-1650 (1991).
Lyman et al,Oncogene, 8(4):815-822 (1993).
Lyman et al,Blood, 83(10):2795-2801 (1994).
Beckmann M. Patricia
Lyman Stewart D.
Gambel Phillip
Immunex Corporation
Sughrue & Mion, PLLC
LandOfFree
Antibodies against flt3-ligand does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies against flt3-ligand, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies against flt3-ligand will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3552312